Ftse Mib
34.242,49
0,00%
DAX
18.430,05
1,42%
S&P 500
5.187,70
0,13%
NASDAQ
16.332,56
-0,10%
Bitcoin
62.684,34
0,56%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cellectis SA (CLLS) Cellectis SA (CLLS) Notizie

Cellectis SA

CLLS
3,1497
-0,2003 (-5,98%)
08 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/5/202412:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/5/202408:00GLOBECellectis Announces Completion of the Additional Equity..
02/5/202422:30GLOBECellectis Appoints Arthur Stril as Interim Chief Financial..
29/4/202422:46GLOBECellectis Reports Financial Results for the Fourth Quarter..
22/4/202422:30GLOBECellectis Presents Novel TALEN® Editing Processes Enabling..
10/4/202422:30GLOBECellectis Publishes a Novel Intronic Gene Editing Approach..
08/4/202422:30GLOBECellectis Announces Two Poster Presentations on Novel TALEN®..
16/1/202422:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/1/202422:30GLOBECellectis announces the drawdown of the second tranche of..
22/12/202322:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/12/202322:30GLOBECellectis Reports Results from Shareholders Meeting Held on..
22/12/202322:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/12/202322:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/11/202322:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/11/202322:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/11/202322:30GLOBECellectis’ Shareholders Meeting to be Held on December 22,..
15/11/202313:48EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/11/202308:30GLOBECellectis Announces the execution of the Subsequent..
09/11/202322:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/11/202322:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/11/202322:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/11/202322:30GLOBECellectis Reports Financial Results for Third Quarter and..
02/11/202321:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/11/202321:30GLOBECellectis to Present Preliminary Results of NATHALI_01 and..
01/11/202321:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/11/202321:30GLOBECellectis to Report Third Quarter 2023 Financial Results on..
01/11/202320:15APSBiotech Shares Soar After AstraZeneca Stake & Research..
01/11/202312:52DJNCellectis Shares Soar Premarket on AstraZeneca Deal
01/11/202312:51DJNCellectis Shares Soar Premarket on AstraZeneca Deal
01/11/202311:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/11/202309:17DJNAstraZeneca to Invest $245 Million in Deal With Cellectis
01/11/202308:00GLOBECellectis Announces Strategic Collaboration and Investment..
31/10/202322:10EDGAR2Form 20-F/A - Annual and transition report of foreign..
31/10/202322:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/10/202321:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/10/202321:30GLOBECellectis Presents Pre-Clinical Data on Multi-armored..
24/10/202322:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/10/202322:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/10/202322:30GLOBECellectis and Imagine Institute Publish A Proof-Of-Concept..
27/9/202322:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/9/202322:30GLOBECellectis to Present Pre-Clinical Data on Multi-armored..
05/9/202322:32EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
07/8/202323:05EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/8/202322:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/8/202322:30GLOBECellectis Provides Full Report for Second Quarter 2023..
07/8/202322:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/8/202322:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/8/202322:30GLOBECellectis Provides Business Updates and Preliminary..
27/7/202322:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/7/202322:30GLOBECellectis to Report Second Quarter 2023 Financial Results on..
Apertura: 3,07 Min: 2,94 Max: 3,19
Chiusura: 3,35

La tua Cronologia

NASDAQ
CLLS
Cellectis
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network